iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.9550
-0.0550 (-5.45%)
Oct 8, 2026, 1:24 PM EDT - Market open
iBio, Inc. Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 0.1 | 0.4 | 0.23 | - | 1.88 | |
Revenue Growth | -75.00% | 77.78% | - | - | -20.54% |
Gross Profit | 0.1 | 0.4 | 0.23 | - | 1.88 |
Selling, General & Admin | 10.6 | 10.69 | 11.67 | 18.45 | 21.75 |
Research & Development | 19.64 | 8.31 | 5.19 | 10.33 | 9.83 |
Operating Expenses | 30.24 | 19 | 16.86 | 28.78 | 31.58 |
Operating Income | -30.14 | -18.6 | -16.63 | -28.78 | -29.7 |
Interest Expense | -0.05 | -0.21 | -0.17 | -0.08 | - |
Interest & Investment Income | 2.15 | 0.44 | 0.36 | 0.21 | 0.18 |
Other Non Operating Income (Expenses) | - | - | - | - | 0.01 |
EBT Excluding Unusual Items | -28.04 | -18.38 | -16.44 | -28.65 | -29.51 |
Gain (Loss) on Sale of Investments | - | - | - | -0.1 | - |
Gain (Loss) on Sale of Assets | - | - | 1 | - | - |
Asset Writedown | -5 | - | - | -0.57 | - |
Pretax Income | -33.04 | -18.38 | -15.44 | -29.31 | -29.51 |
Earnings From Continuing Operations | -33.04 | -18.38 | -15.44 | -29.31 | -29.51 |
Earnings From Discontinued Operations | - | - | -9.46 | -35.7 | -20.79 |
Net Income to Company | -33.04 | -18.38 | -24.91 | -65.01 | -50.3 |
Minority Interest in Earnings | - | - | - | - | 0 |
Net Income | -33.04 | -18.38 | -24.91 | -65.01 | -50.3 |
Preferred Dividends & Other Adjustments | - | - | - | - | 0.09 |
Net Income to Common | -33.04 | -18.38 | -24.91 | -65.01 | -50.39 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 104 | 10 | 4 | 1 | 0 |
Shares Outstanding (Diluted) | 104 | 10 | 4 | 1 | 0 |
Shares Change | 891.14% | 174.05% | 525.98% | 40.35% | 11.45% |
EPS (Basic) | -0.32 | -1.75 | -6.50 | -106.23 | -115.56 |
EPS (Diluted) | -0.32 | -1.75 | -6.50 | -106.23 | -115.56 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -23.8 | -15.32 | -18.76 | -36.87 | -44.81 |
Free Cash Flow Per Share | -0.23 | -1.46 | -4.90 | -60.24 | -102.76 |
Gross Margin | 100.00% | 100.00% | 100.00% | - | 100.00% |
Operating Margin | -30138.00% | -4650.50% | -7392.89% | - | -1576.27% |
Profit Margin | -33044.00% | -4594.25% | -11069.78% | - | -2674.68% |
Free Cash Flow Margin | -23796.00% | -3830.00% | -8339.56% | - | -2378.45% |
EBITDA | -29.49 | -17.83 | -15.71 | -28.05 | -29.3 |
D&A For EBITDA | 0.65 | 0.78 | 0.93 | 0.73 | 0.4 |
EBIT | -30.14 | -18.6 | -16.63 | -28.78 | -29.7 |